Audits

  • Inspection of the BI 1220.7 study by the US Food and Drug Administration (FDA), March/April 2014
  • Audit of the Bionor Vacc-4x IMiD/-2010/1, set by the CRO, Aptiv Solutions, November 2013
  • Audit of the A4001095 study set by the sponsor Pfizer, May 2013.
  • Audit of the GS-US-264-0106 study set by the sponsor Gilead Sciences, November 2011.
  • Audit of the ING114467 study set by the sponsor GlaxoSmithKline, October 2011.
  • Audit of the BI 1100.1486 study set by the sponsor Boehringer Ingelheim, April 2009.
  • GCP-audit (Inspektion) of the BI 1182.107 study by the Landesamt für Gesundheit und Soziales Berlin, June/July 2008.
  • Audit of the AI 424-138 study set by the sponsor Bristol-Myers-Squibb, November 2006.
  • Audit of the WV16789 study, set by the sponsor ROCHE, May 2004.
  • Audit of the BI 1182.52 study set by the sponsor Boehringer Ingelheim, January 2003.
  • GCP-audit of the APV 30005 study set by the sponsor GlaxoSmithKline, October 2002.

Last change: 05/08/2014